Study of the effect of intrathecal dexmedetomidine as an adjuvant in spinal anesthesia for Gynaecological Surgery.
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
- Peoples Hospital
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- motor block regession in bromage score,sensory
Study Overview
Brief Summary
•Study the effect of intrathecal dexmedetomidine for prolongation of spinal analgesia..
OBJECTIVES:-
•To see the effect of intrathecal dexmedetomidine for prolongation of spinal analgesia.
•To study onset and level of sensory and motor block.
•To monitor the quality of analgesia with its duration.
•To study the side effects if any.
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Participant and Outcome Assessor Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •1.ASA grade I and II patients.
- •2.Age group 18-60 years.
- •Gynecological surgeries.
Exclusion Criteria
- •Patient refusal or unco-opretive patient
- •Bleeding disorder
- •Neurological deficit.
- •History of seizures 5.
Outcomes
Primary Outcomes
motor block regession in bromage score,sensory
Time Frame: 4 to 8 hours after intra thecal injection
block regession by pin prick senstion to
Time Frame: 4 to 8 hours after intra thecal injection
analgesic in post operative period,any other side
Time Frame: 4 to 8 hours after intra thecal injection
dermatomes,time to requirement to first
Time Frame: 4 to 8 hours after intra thecal injection
effects like nausea,headache,itching etc
Time Frame: 4 to 8 hours after intra thecal injection
Secondary Outcomes
- sensory block regession by pin prick senstion to(dermatomes,time to requirement to first)